Discover 1,672 paid clinical trials in Sandy Springs, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,672
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
for
Low Grade Upper Tract Urothelial Carcinoma
Location: Atlanta GA, Nashville TN, Mt. Pleasant SC,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 18+
Code: NCT07265947
Phase 2, Recruiting
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
for
Glioblastoma
Location: Atlanta GA, Orlando FL, Greenville NC, Columbus OH,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT07195591
Phase 3, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Gainesville GA, Athens GA, Anderson SC, Columbus MS,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase 2, Recruiting
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
for
Multiple Myeloma (MM)
Location: Atlanta GA, Louisville KY, Durham NC, Baltimore MD,
Sponsor: C4 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07280013
Phase 1, Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
for
Cervical Carcinoma, Human Papillomavirus Infection
Location: Atlanta GA, Birmingham AL, Chapel Hill NC,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 25+
Code: NCT07281430
Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Atlanta GA, Greenville SC, Augusta GA, Nashville TN,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase 1, Recruiting
Study of ALTO-300 in MDD
for
Major Depressive Disorder
Location: Snellville GA, Hickory NC, Savannah GA, Roanoke VA,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT05922878
Phase 2, Recruiting
Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors
for
Malignant Brain Glioma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 0 - 21
Code: NCT04908709
Recruiting
Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
for
Locally Advanced Adrenal Cortex Carcinoma,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06006013
Phase 2, Recruiting
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
for
Plasma Cell Myeloma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT05208307
Phase 2, Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Hematological Malignancies
Location: Atlanta GA, Birmingham AL, Louisville KY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04634552
Phase 2, Recruiting
MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial
for
Malignant Testicular Germ Cell Tumor
Location: Atlanta GA, Birmingham AL, New Brunswick NJ, Toronto,
Sponsor: University of Southern California
Sex: Male
Age: 18+
Code: NCT06060873
Recruiting
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Atlanta GA, Homewood AL, Tampa FL, Indianapolis IN,
Sponsor: Oncolytics Biotech
Sex: All
Age: 18+
Code: NCT07446322
Phase 2, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Atlanta GA, Nashville TN, Jacksonville FL, Durham NC,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase 3, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Atlanta GA, Winston-Salem NC, Lexington KY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase 1, Phase 2, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Atlanta GA, Seneca SC, Easley SC, Greenville SC,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase 3, Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection